ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2034

Novel Susceptible Genes for Behçet’s Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure

Masaki Takeuchi1,2, Nobuhisa Mizuki3, Akira Meguro4, Michael J. Ombrello5, Yohei Kirino6, Colleen Satorius7, Julie Le1, Mary Blake8, Burak Erer9, Tatsukata Kawagoe2, Duran Ustek10, Ilknur Tugal-tutkun11, Emire Seyahi12, Yilmaz Ozyazgan13, Inês Sousa14, Fereydoun Davatchi15, Vânia Francisco14, Farhad Shahram16, Bahar Abdollahi17, Abdolhadi Nadji17, Niloofar Shafiee17, Fahmida Ghaderibarmi18, Shigeaki Ohno19, Atsuhisa Ueda6, Yoshiaki Ishigatsubo20, Massimo G. Gadina21, Sofia Oliveira14, Ahmet Gul9, Daniel L. Kastner1 and Elaine F. Remmers22, 1National Human Genome Research Institute, Bethesda, MD, 2Yokohama City University Graduate School of Medicine, Yokohama, Japan, 3Yokohama City University, Yokohama, Japan, 4Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 5Translational Genetics and Genomics Unit, NIAMS, NIH, Bethesda, MD, 6Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 7NIAMS, N.I.H, Bethesda, MD, 8National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 9Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 10Istanbul University, Istanbul, Turkey, 11Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, 12Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 13Ophthalmology, Istanbul University, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, 14Universidade de Lisboa, Lisboa, Portugal, 15Internal Medicine, Rheumatology Research Ctr-Tehran Univ, Tehran, Iran, 16Tehran University of Medical Sciences, Tehran, Iran (Islamic Republic of), 17Tehran University of Medical Sciences, Teheran, Iran (Islamic Republic of), 18Tehran University of Medical Sciences, Teheran, Portugal, 19Hokkaido University Graduate School of Medicine, Hokkaido, Japan, 20Int. Med. & Clin. Immunology, Yokohama City Grad Sch of Med, Yokohama, Japan, 21Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 22National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome, IL-1 and major histocompatibility complex (MHC)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Genetics, Genomics and Proteomics I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:  Recent genetic studies have identified multiple susceptibility loci for Behçet’s disease. However, these genetic factors do not fully explain the apparent disease heritability.The purpose of this study was to densely genotype loci associated with immune-related diseases to identify novel susceptibility loci for Behçet’s disease.

Methods:  1900 Turkish Behçet’s disease patients and 1779 controls were genotyped using the Immunochip. For novel loci with association test P<5×10-5, additional SNPs in the region were genotyped or imputed using 1000 Genomes Project data as a reference. For replication, the lead genotyped SNP in each novel locus with P<5×10-5 in the Turkish population was genotyped in 982 cases and 826 controls from Iran. We also replicated disease associations with imputed previous GWAS data from 608 Japanese cases and 737 controls. P<5×10-8was considered the threshold for genome-wide significance.

Results:  HLA-B*51 was the strongest associated marker and rs1050502 the strongest associated SNP. rs1050502 is located in exon 2 of HLA-B and the risk allele T is a tag SNP for HLA-B*51. Outside of the MHC region, we identified 4 novel loci, IL1A-IL1B, ADO-EGR2, IRF8, and CEBPB-PTPN1, which exceeded genome-wide significance in Turks. Genotyping Iranian samples and meta-analysis with Turkish data replicated associations of three loci, ADO-EGR2, IRF8 and CEBPB-PTPN1. Comprehensive meta-analysis of the regional imputed genotype data of Turks and Japanese replicated two loci, ADO-EGR2 and IRF8, and revealed two additional novel loci, RIPK2 and LACC1. The disease associated allele of rs4402765, the lead marker of the IL1A-IL1B locus, was associated with both decreased interleukin-1α and increased interleukin-1β protein production. Ancestry specific FUT2non-secretor genotypes, homozygous rs601338 (p.Trp143Ter) in Turks and Iranians and rs1047781 (p.Ile129Phe) in Japanese, showed strong disease association. The non-secretor genotype has been associated with Crohn’s disease and gut microbiome composition.

Conclusion:  Here, we conducted an Immunochip study in the largest Behçet’s disease discovery cohort ever with multiple populations for replication. This study identified 6 novel loci (IL1A-IL1B, RIPK2, ADO-EGR2, LACC1, IRF8, and CEBPB-PTPN1) with genome-wide significance for Behçet’s disease. Our findings that the disease-associated allele of IL1A is associated with dysregulated IL-1 biology, with less IL-1alpha and more IL-1beta production, and that functionally defective structural FUT2 variants are associated with disease risk suggest that an impaired host response to microbes, including those of the microbiome, may contribute to Behçet’s disease susceptibility.


Disclosure: M. Takeuchi, None; N. Mizuki, None; A. Meguro, None; M. J. Ombrello, None; Y. Kirino, None; C. Satorius, None; J. Le, None; M. Blake, None; B. Erer, None; T. Kawagoe, None; D. Ustek, None; I. Tugal-tutkun, None; E. Seyahi, None; Y. Ozyazgan, None; I. Sousa, None; F. Davatchi, None; V. Francisco, None; F. Shahram, None; B. Abdollahi, None; A. Nadji, None; N. Shafiee, None; F. Ghaderibarmi, None; S. Ohno, None; A. Ueda, None; Y. Ishigatsubo, None; M. G. Gadina, None; S. Oliveira, None; A. Gul, None; D. L. Kastner, None; E. F. Remmers, None.

To cite this abstract in AMA style:

Takeuchi M, Mizuki N, Meguro A, Ombrello MJ, Kirino Y, Satorius C, Le J, Blake M, Erer B, Kawagoe T, Ustek D, Tugal-tutkun I, Seyahi E, Ozyazgan Y, Sousa I, Davatchi F, Francisco V, Shahram F, Abdollahi B, Nadji A, Shafiee N, Ghaderibarmi F, Ohno S, Ueda A, Ishigatsubo Y, Gadina MG, Oliveira S, Gul A, Kastner DL, Remmers EF. Novel Susceptible Genes for Behçet’s Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/novel-susceptible-genes-for-behcets-disease-identified-by-dense-genotyping-of-immune-related-loci-implicate-host-responses-to-microbial-exposure/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-susceptible-genes-for-behcets-disease-identified-by-dense-genotyping-of-immune-related-loci-implicate-host-responses-to-microbial-exposure/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology